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Summary Tumour cells exposed to hypoxia in vitro can show increased expression of several selected genes, including the gene encoding
the vascular endothelial growth factor (VEGF), suggesting that hypoxia followed by reoxygenation might promote the malignant progression of
tumours. An in vitro/in vivo study was conducted to investigate whether hypoxia can increase the angiogenic potential of tumour cells through
increased VEGF secretion. Four human melanoma cell lines (A-07, D-12, R-18, U-25) were included in the study. Cell cultures were exposed
to hypoxia (oxygen concentration <10 p.p.m.) in vitro using the steel chamber method. Rate of VEGF secretion was measured in vitro in
aerobic and hypoxic cell cultures by ELISA. Angiogenesis was assessed in vivo using the intradermal angiogenesis assay. Aliquots of cells
harvested from aerobic cultures or cultures exposed to hypoxia for 24 h were inoculated intradermally in the flanks of adult female BALB/c-
nu/nu mice. Tumours developed and angiogenesis was quantified by scoring the number of capillaries in the dermis oriented towards the
tumours. The number of tumour-oriented capillaries did not differ significantly between tumours from hypoxic and aerobic cultures for
A-07 and U-25, whereas tumours from hypoxic cultures showed a larger number of tumour-oriented capillaries than tumours from aerobic
cultures for D-12 and R-18. The VEGF secretion under aerobic conditions and the absolute increase in VEGF secretion induced by hypoxia
were lower for D-12 and R-18 than for A-07 and U-25, whereas the relative increase in VEGF secretion induced by hypoxia was higher for
D-12 and R-18 than forA-07 and U-25. VEGF is not a limiting factor in the angiogenesis of some tumours under normoxic conditions. Hypoxia
can increase the angiogenic potential of tumour cells by increasing the secretion of VEGF, but only of tumour cells showing low VEGF
secretion under normoxia. Transient hypoxia might promote the malignant progression of tumours by temporarily increasing the angiogenic
potential of tumour cells showing low VEGF expression under normoxic conditions.
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Many malignant tumours develop regions of hypoxic cells during
growth (Coleman, 1988; Vaupel et al, 1989; Brown and Giaccia,
1994). Two types of hypoxia have been recognized: chronic
hypoxia, arising from limitations in oxygen diffusion, and acute
hypoxia, resulting from transient stoppages in microregional
blood flow (Stone et al, 1993; Horsman, 1995). Reoxygenation of
hypoxic cells occurs during unperturbed tumour growth as a result
ofreopening oftemporarily closed vessels and during therapy as a
result oftherapy-induced tumour cell inactivation (Kallman, 1972;
Brown, 1979; Chaplin et al, 1987). Hypoxia followed by reoxy-
genation might promote the malignant progression of tumours
(Hill, 1990). Thus, tumour cells exposed to hypoxia in vitro can
show increased expression of several selected genes, including
genes encoding cell cycle-regulatory proteins, haematopoietic
and/or vascular regulatory proteins, metastasis-promoting
proteins, viral proteins, metabolic enzymes and transcription
factors (Brown and Giaccia, 1994; Dachs and Stratford, 1996).
Hypoxia-response elements governing the increased gene expres-
sion in response to hypoxia have been discovered in the vicinity
of most of these genes (Dachs and Stratford, 1996). Moreover,
tumour cells subjected to transient hypoxia in vitro can show
increased metastatic potential in vivo (Young and Hill, 1988) and
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increased resistance to some chemotherapeutic agents (Rice et al,
1987; Luk et al, 1990; Sanna and Rofstad, 1994). Exposure of
tumour cells to transient hypoxia in vitro can also induce cell
subpopulations showing a slightly increased DNA content (Rice et
al, 1986; Wilson et al, 1989) or a doubling of the number of
chromosomes (Rofstad et al, 1996). Finally, clinical studies have
indicated that tumours showing low oxygen tensions or high
lactate concentrations may have a higher metastatic potential than
tumours showing high oxygen tensions or low lactate concentra-
tions (Schwickert et al, 1995; Brizel et al, 1996; Hockel et al,
1996; Walenta et al, 1997).
Tumour angiogenesis plays an important role in the progression
of malignant diseases (Folkman, 1985). Thus, angiogenesis is
necessary for a tumour to grow beyond a certain size, given by the
diffusion distances ofoxygen and other nutrients (Folkman, 1990).
The process of angiogenesis is also a critical determinant of the
growth rate ofprimary tumours and the development ofmetastases
(Fidler and Ellis, 1994). Tumour angiogenesis is regulated by
several stimulatory and inhibitory angiogenic factors (Folkman and
Klagsbrun, 1987). The stimulatory angiogenic factor that presently
receives the greatest attention is the vascular endothelial growth
factor (VEGF) (Hlatky et al, 1996). VEGF, a 45-kDa heparin-
binding glycoprotein dimer existing in four different isoforms
(VEGF121165,189,206) arising from alternative m-RNA splicing, is
a specific endothelial cell mitogen (Zagzag, 1995). Some
xenografted tumours established from cell lines transfected with
VEGF show increased vascular density and metastatic frequency
relative to non-transfected control tumours (Claffey et al, 1996;
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Potgens et al, 1996). Northern and Western blot analyses have
shown that VEGF can be up-regulated in tumour cells exposed to
hypoxia in vitro (Shweiki et al, 1995; Waleh et al, 1995). Tumour
cells adjacent to necrotic regions can show increased VEGFexpres-
sion, as revealed by in situ hybridization (Plate et al, 1992; Shweiki
et al, 1992). It is therefore possible that tumour hypoxia causes
increased angiogenesis through increased VEGF synthesis and
secretion, and hence promotes malignant progression. The purpose
of the work reported here was to test this hypothesis. Cells from
four human melanoma cell lines differing in angiogenic potential
were exposed to hypoxia in vitro. VEGF secretion was measured in
vitro by ELISA and angiogenesis was assessed in athymic nude
mice using the intradermal angiogenesis assay.
MATERIALS AND METHODS
Cell lines
Four human melanoma cell lines (A-07, D-12, R-18, U-25) were
included in the study (Rofstad, 1994). The cell lines were main-
tained in monolayer culture in RPMI 1640 medium (25 mM
HEPES andL-glutamine) supplemented with 13% fetal calfserum,
250 mg 1-' penicillin and 50 mg 1-' streptomycin. The cultures
were incubated at 37°C in a humidified atmosphere of 5% carbon
dioxide in air and subcultured twice a week by trypsinization
(treatment with 0.05% trypsin/0.02% EDTA solution at 37°C for 2
min). The cell lines were verified to be free from Mycoplasma
contamination using the Hoechst fluorescence and the mycotrin
methods (Chen, 1977).
Hypoxia exposure
Monolayer cell cultures growing in glass dishes were exposed to
hypoxia using the steel chamber method (Sanna and Rofstad,
1994). The cultures were incubated at 37°C in a humidified atmos-
phere of 5% carbon dioxide in air for 24 h before the hypoxia
treatment. The culture medium was removed andreplaced by fresh
medium immediately before the cells were exposed to hypoxia.
The medium used during the hypoxia treatment was supplemented
with 2.2 g 1-1 sodium bicarbonate. The pH of the medium was
7.4 ± 0.1. The glass dishes were kept in air-tight steel chambers
during the hypoxia treatment. The medium layer covering the cells
was approximately 2 mm in thickness. The steel chambers were
flushed with a humidified, highly purified gas mixture consisting
of95% nitrogen and 5% carbon dioxide at aflow rate of5 1 min-m.
Measurements showed that the concentration of oxygen in the
medium was less than 10 p.p.m. after 30 min of flushing. Control
cultures were flushed with humidified 5% carbon dioxide in air.
After the hypoxia treatment, the cells were detached from the glass
dishes by trypsinization and washed in Ca2+- andMg2+-free Hanks'
balanced salt solution (HBSS).
VEGF secretion
VEGF concentration in culture medium was measured using a
commercially available humanVEGF165ELISA kit (R&D Systems,
Minneapolis, MN, USA) according to the manufacturer's instruc-
tions. Medium samples were collected from cell cultures immedi-
ately before and after a 24-h hypoxia treatment, centrifuged to
remove particulates and assayed in duplicate. Absorbances were
read at 450 nm. Readings at 570 nm were subtracted from the
readings at450 nm to correctforoptical imperfections in theplates.
Rate ofVEGF secretion (Rsec) was calculated as:
VAC In(Nf/Nj)
sec NiAt (Nf/Nj- 1)
where AC is the increase in VEGF concentration during the time
interval At (24 h), N, and Nf are the initial and final cell numbers
and V is the volume of medium. The second factor ofthis product
is based on the assumption that the cell number increased expo-
nentially with time during At, an assumption that was verified to be
fulfilled for aerobic control cultures. There was no significant cell
proliferation underhypoxic conditions, i.e. the second factor ofthe
product was - 1 for hypoxic cultures. Replicate cell cultures were
used to determine N.. Cell numbers were counted using a haemo-
cytometer and a phase-contrast microscope.
Angiogenesis
Angiogenic potential was assessed in vivo using the intradermal
angiogenesis assay (Kreisle and Ershler, 1988; Runkel et al, 1991).
Adult female BALB/c-nu/nu mice, bred at our research institute,
were used as test animals. The mice were maintained under
pathogen-free conditions at constant temperature (24-26°C) and
humidity (30-50%). Sterilized food and tap water were given ad
libitum. Animal care was in accord with institutional guidelines.
Cells were harvested from aerobic control cultures or cultures
exposed to hypoxia for 24 h. Aliquots of the cells, suspended in
10 ,ul ofCa2+- and Mg2+-free HBSS, were inoculated intradermally
in the flanks of mice using a 100-gl Hamilton syringe (Rofstad,
1994). The skin around the inoculation sites was removed at
predetermined times after the inoculation when small tumours had
developed. The tumours were located with a dissecting micro-
scope, and angiogenesis was quantified by counting the capillaries
oriented towards the tumours (Rofstad, 1994). The number of
capillaries was corrected for the background, determined after
injection of 10gl ofHBSS. The tumours were dissected free from
the skin and weighed after the tumour oriented capillaries had
been scored.
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Figure 1 Number of tumour-oriented capillaries vs cell line for human
melanoma cells inoculated intradermally in female BALB/c-nu/nu mice. The
tumour-oriented capillaries were scored 7 days after the inoculation of
3.5 x 105 cells from aerobic cultures. Mean values (columns) and s.e. (bars)
of 22-24 tumours
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Figure 2 Number of tumour-oriented capillaries vs number of cells per
inoculum for human melanoma cells inoculated intradermally in female
BALB/c-nu/nu mice. The tumour-oriented capillaries were scored 5 days
(A-07), 7 days (D-12) or 14 days (R-18, U-25) after the cell inoculation. The
cells were harvested from aerobic control cultures (0) or cultures exposed to
hypoxia for 24 h (0). Mean values (points) and s.e. (bars) of 12 tumours
Statistical analysis
Results are presented as arithmetic mean ± s.e. Linear regression
analysis was performed on plots of number of capillaries vs cell
number, tumour weight vs cell number, and tumour weight vs
number of capillaries. Statistical comparisons of mean values
(number of capillaries, tumour weight, VEGF secretion) were
performed under conditions of normality and equal variance using
the Student's t-test (paired or unpaired) for single comparisons and
one-way ANOVA and the Student-Newman-Keuls test for multiple
comparisons. Logarithmic transformation ofthe data was performed
when appropriate (Altman, 1991). All P-values were determined
from two-sided tests. A significance criterion ofP < 0.05 was used.
The statistical analysis was performed using SigmaStat statistical
software (Jandel Scientific, Erkrath, Germany).
RESULTS
Inoculation oftumour cells evoked a strong angiogenic response in
the mouse dermis. Capillaries oriented towards the inoculum were
formed, and after a few days depending on the cell line and the
number of cells inoculated, the new capillaries penetrated the
inoculum and a small vascularized tumour arose. The number of
capillaries oriented towards a tumour increased with the time after
inoculation (data not shown). The angiogenic response was cell
line dependent. This is illustrated in Figure 1, which shows the
number of tumour-oriented capillaries at day 7 after the inocula-
tion of 3.5 x 105 cells from aerobic cultures. The sequence of the
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Figure 3 Tumour weight vs number of cells per inoculum for human
melanoma cells inoculated intradermally in female BALB/c-nu/nu mice. The
tumour weights were determined 5 days (A-07), 7 days (D-12) or 14 days
(R-18, U-25) after the cell inoculation. The cells were harvested from aerobic
control cultures (0) or cultures exposed to hypoxia for 24 h (0). Mean values
(points) and s.e. (bars) of 12 tumours
cell lines from high to low values of the number of capillaries
was: A-07, D-12, R-18, U-25 [A-07 vs D-12 (P < 0.0005), D-12 vs
R-18 (P < 0.05), R-18 vs U-25 (P < 0.01)].
In Figure 2, the angiogenic response evoked by cells from
cultures exposed to a 24-h hypoxia treatment is compared with that
evoked by cells from aerobic control cultures. The plot shows the
number of tumour-oriented capillaries vs the number of cells per
inoculum. The cells were inoculated immediately after the hypoxia
treatment and the capillaries were scored at day 5 (A-07), day 7
(D-12) or day 14 (R-18, U-25) after the inoculation. The time
interval from cell inoculation to capillary scoring was varied
because the rate of angiogenesis differed among the cell lines. The
number ofcapillaries did not differbetween tumours from hypoxic
cultures and those from aerobic cultures for A-07 (P > 0.05) and
U-25 (P > 0.05). In contrast, tumours from hypoxic cultures
showed a larger number of capillaries than tumours from aerobic
cultures for D-12 (P < 0.0005) and R-18 (P < 0.005).
Figure 3 refers to the same experiments as Figure 2 and shows
tumour weight vs the number ofcells per inoculum. The weight did
not differ between tumours from hypoxic cultures and those from
aerobic cultures for A-07 (P > 0.05) and U-25 (P > 0.05). In
contrast, cells from hypoxic cultures gave rise to larger tumours
than cells from aerobic cultures for D-12 (P < 0.001) and R-18
(P < 0.005). The similarities in Figures 2 and 3 suggest that the
weight of the tumours was closely related to the angiogenic
response evoked by the cell inocula. In fact, there was a strong
correlation between tumour weight and the number of tumour-
oriented capillaries for each cell line (P < 0.0001) (data not shown).
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Figure 4 Rate of VEGF secretion vs cell line for human melanoma cells
grown in monolayer culture in vitro. Hypoxic cultures are compared with
aerobic control cultures. Mean values (points) and s.e. (bars) of three to
seven experiments
The rate of VEGF secretion in vitro differed among the cell
lines (Figure 4). A-07 showed a higher secretion rate than U-25
(P < 0.05), which in turn showed a higher secretion rate than D-12
and R-18 (P < 0.05), under both aerobic and hypoxic conditions.
The secretion rates were higher for hypoxic cultures than for
aerobic control cultures for all four cell lines (P < 0.001 for D-12,
R-18 and U-25; P < 0.05 for A-07). The mean values for hypoxic
cultures were higher than those for aerobic cultures by factors of
approximately 1.5 (A-07), 7 (D-12), 10 (R-18) and 4 (U-25). D-12
and R-18, which had the lowest secretion rates under aerobic
conditions, showed the highest relative increases in secretion rate
induced by hypoxia. However, the absolute increases in VEGF
secretion induced by hypoxia were lower for D-12 and R-18 than
for A-07 and U-25 (Figure 4).
DISCUSSION
Direct evidence that hypoxia can promote tumour angiogenesis
has not been published so far. However, it has been hypothesized
that the development of hypoxic regions in tumours leads to
increased angiogenesis through increased synthesis and secretion
of VEGF (Claffey and Robinson, 1996; Hlatky et al, 1996).
Several angiogenic factors can be involved in tumour angiogenesis
(Folkman and Klagsbrun, 1987), and the hypothesis is based on
the assumptions that tumour angiogenesis is limited by the
concentration of VEGF and that hypoxia can increase VEGF
synthesis and secretion to an extent that is sufficient to increase
tumour angiogenesis. The following observations support the
hypothesis. Tumour cells exposed to hypoxia in vitro can show
increased levels of VEGF m-RNA and protein (Shweiki et al,
1995; Waleh et al, 1995). The VEGF expression in multicellular
spheroids and solid tumours is usually enhanced in regions
believed to be hypoxic (Plate et al, 1992; Shweiki et al, 1992,
1995; Waleh et al, 1995). VEGF has been shown to be a specific
endothelial cell mitogen in vitro (Gospodarowicz et al, 1989). Two
high-affinity VEGF receptors (flt-I and KDR) have been recog-
nized on human endothelial cells (de Vries et al, 1992; Terman
et al, 1992). The expression of VEGF is correlated to vascular
density in several histological types of human tumours (Guidi et
al, 1995; Takahashi et al, 1995; Toi et al, 1995; Mattern et al,
1996). Experimental tumours transfected with VEGF can show a
higher vascular density and volumetric growth rate than wild-type
control tumours (Zhang et al, 1995; Claffey et al, 1996; Potgens et
al, 1996), whereas tumours initiated from cells transfected with
antisense-VEGF c-DNA can show reduced vascular density and
growth in vivo (Saleh et al, 1996). The neovascularization and
growth ofexperimental tumours can be inhibited by treatment with
monoclonal antibodies against VEGF (Kim et al, 1993; Asano et
al, 1995; Melnyk et al, 1996). Finally, VEGF increases microvas-
cular permeability to macromolecules, thereby leading to
fibrinogen extravasation and fibrin deposition, which are impor-
tant processes in tumour angiogenesis (Senger et al, 1993).
Detailed studies of hypoxia-induced tumour angiogenesis
require the use of adequate experimental end points. Thus, the
number of tumour-oriented capillaries, determined using the intra-
dermal angiogenesis assay, was applied as end point for tumour
angiogenesis in the present work. Many investigators use tumour
vascular density as a measure of angiogenic potential. However,
the vascular density of tumours is not only governed by the rate of
neovascularization, as is the number oftumour-oriented capillaries
at a given time after tumour cell inoculation. Other biological
properties of tumours, such as the rates of cell proliferation and
development of necrosis, have substantial influence on vascular
density. Moreover, hypoxia-induced VEGF up-regulation was
studied here by measuring the rate of VEGF secretion in units of
pg 10 6 cells h-I in aerobic and hypoxic cell cultures. This end
point is probably more relevant for the rate of neovascularization
than the levels of VEGF m-RNA and protein determined by
Northern and Western blot analyses. Studies in our laboratory have
shown that the rate of VEGF secretion cannot be predicted from
the cellular content of VEGF protein.
A-07, D-12, R-18 and U-25 differed substantially in rate of
VEGF secretion under aerobic conditions. Oncogenic transforma-
tion of cells with activated forms of the ras oncogene has been
shown to increase the expression ofVEGF (Grugel et al, 1995; Rak
et al, 1995; Mazure et al, 1996). Flow cytometric analysis has
shown that the constitutive level of ras protein is significantly
higher in A-07 than in D-12, R-18 and U-25. The position ofthe ras
protein bands in Western blots does not differ among the cell lines.
The study reported here is the first to establish a connection
between hypoxia, tumour angiogenesis and hypoxia-induced
VEGF up-regulation. The data on D-12 and R-18 show that
tumour cells exposed to hypoxic conditions can have a higher
angiogenic potential than aerobic tumour cells. Thus, the number
of tumour-oriented capillaries was higher for tumours initiated
from hypoxia-treated cultures than for tumours initiated from
aerobic control cultures. Moreover, the tumours initiated from
hypoxia-treated cultures were larger than the tumours initiated
from control cultures, suggesting that the increased angiogenesis
led to increased tumour growth. The increases in the number of
tumour-oriented capillaries and the tumour weight were probably
a consequence of increased VEGF secretion. The rate of VEGF
secretion was higher for hypoxic cultures than for aerobic cultures
by factors of approximately 7 (D-12) and 10 (R-18).
Northern blot analyses have shown that hypoxia-induced VEGF
up-regulation decreases with time after reoxygenation (Hlatky et
al, 1994). Thus, VEGF was probably not up-regulated during the
whole period from cell inoculation to capillary scoring in the
tumours initiated from hypoxia-treated cultures. However, in D-12
and R-18, the tumours initiated from hypoxia-treated cultures
might still have shown a higher rate ofVEGF secretion during the
whole period than the tumours initiated from control cultures, as
they grew fasterthan the control tumours and thus, at similartimes
after cell inoculation, contained a larger number of secreting cells.
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It should also be noted that the cells derived from hypoxia-
treated cultures were aerobic at the time of inoculation in athymic
mice. The possibility thus exists that the experiments reported here
underestimate the magnitude of hypoxia-induced angiogenesis.
The time interval between the opening of the hypoxia chambers
and the cell inoculation was kept as short as possible (<1 h) to
minimize possible effects ofreoxygenation.
The study reported here also suggests that exposure to hypoxia
does not increase the angiogenic potential of the cells of all
tumours. Thus, the A-07 and U-25 tumours did not show a higher
number of tumour-oriented capillaries when initiated from
hypoxia-treated cultures than when initiated from aerobic control
cultures, despite the fact that the rate ofVEGF secretion was higher
for hypoxic cultures than for aerobic cultures by factors of approx-
imately 1.5 (A-07) and 4 (U-25). The tumour weights did not differ
significantly between the tumours initiated from hypoxia-treated
cultures and the tumours initiated from aerobic cultures either.
Although the hypoxia-induced relative increases in VEGF
secretion were lower for A-07 and U-25 cells than for D-12 and
R-18 cells, the A-07 and U-25 cells showed the largest absolute
increases. Consequently, the differences between the A-07 and
U-25 cells and the D-12 and R-18 cells in hypoxia-induced angio-
genesis cannot be attributed to differences in hypoxia-induced
VEGF up-regulation. The differences between the A-07 and U-25
cells and the D-12 and R-18 cells are probably not a consequence
of differences in angiogenic potential under aerobic conditions
either, in that the sequence ofthe lines from high to low angiogenic
potential was found to be: A-07, D-12, R-18, U-25 (Figure 1).
The VEGF secretion data, however, offer a plausible explana-
tion as to why exposure to hypoxia increased the angiogenic
potential of the D-12 and R-18 cells but not of the A-07 and U-25
cells. The D-12 and R-18 cells showed lower rates ofVEGF secre-
tion under aerobic conditions than the A-07 and U-25 cells. It is
therefore possible that the angiogenesis of control D-12 and R-18
tumours was limited by the rate of VEGF secretion. Hypoxia-
induced VEGF up-regulation therefore led to increased angio-
genesis. In contrast, the rate ofVEGF secretion was probably not a
limiting factor in the angiogenesis of control A-07 and U-25
tumours. Exposure to hypoxia therefore just led to secretion of
redundant VEGF. It should be noticed that the VEGF secretion of
the D-12 and R-18 cells under hypoxic conditions was similar to
that of the U-25 cells under aerobic conditions. If our interpreta-
tion is correct, it can be concluded that (a) VEGF is not a limiting
factor in the angiogenesis of some tumours under normoxic condi-
tions and (b) the hypoxia-induced VEGF up-regulation in low
VEGF-expressing tumour cells can be sufficiently large to elimi-
nate VEGF as a limiting factor in the rate of neovascularization.
Tumours gradually develop aggressive phenotypic traits during
growth, including the invasion of surrounding normal tissue and
the dissemination of metastases. This process is termed the
malignant progression of tumours and is probably a result of the
genomic instability of tumour cells (Hill, 1990). Recent studies
have suggested that microenvironmental conditions known to
occur in tumours, such as hypoxia and reoxygenation, might
increase the genomic instability and hence promote the malignant
progression (Hill, 1990; Brown and Giaccia, 1994; Dachs and
Stratford, 1996; Hlatky et al, 1996). The study reported here
suggests that hypoxia might also promote the malignant progres-
sion by increasing the angiogenic potential oftumour cells through
increased synthesis and secretion of VEGF. It should be noted,
however, that hypoxia-induced VEGF up-regulation probably
results in increased angiogenic potential only in tumour cells
showing low VEGF expression under normoxic conditions. It
should also be noted that hypoxia-induced VEGF up-regulation
and the accompanying increased angiogenic potential is a transient
phenomenon in acutely hypoxic cells; the VEGF expression prob-
ably returns gradually to normoxic levels after the reopening of
temporarily closed vessels. However, a transient increase in the
angiogenic potential of low VEGF-expressing tumour cells might
be all that is required for some of the stages of the malignant
progression of tumours, including some processes involved in the
invasion ofnormal tissue and the dissemination of metastases.
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